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MicroRNA-155 is essential for the optimal proliferation
and survival of plasmablast B cells
Giuseppina Arbore1,* , Tom Henley1,*, Laura Biggins3, Simon Andrews3, Elena Vigorito1, Martin Turner1 ,
Rebecca Leyland1,2
A fast antibody response can be critical to contain rapidly di-
viding pathogens. This can be achieved by the expansion of
antigen-speciﬁc B cells in response to T-cell help followed by
differentiation into plasmablasts. MicroRNA-155 (miR-155) is re-
quired for optimal T-cell–dependent extrafollicular responses via
regulation of PU.1, although the cellular processes underlying this
defect are largely unknown. Here, we show that miR-155 regulates
the early expansion of B-blasts and later on the survival and
proliferation of plasmablasts in a B-cell–intrinsic manner, by
tracking antigen-speciﬁc B cells in vivo since the onset of antigen
stimulation. In agreement, comparative analysis of the tran-
scriptome of miR-155–sufﬁcient and miR-155–deﬁcient plasma-
blasts at the peak of the response showed that the main
processes regulated bymiR-155 were DNAmetabolic process, DNA
replication, and cell cycle. Thus, miR-155 controls the extent of
the extrafollicular response by regulating the survival and pro-
liferation of B-blasts, plasmablasts and, consequently, antibody
production.
DOI 10.26508/lsa.201800244 | Received 14 November 2018 | Revised 29 April
2019 | Accepted 30 April 2019 | Published online 16 May 2019
Introduction
Optimal humoral responses against foreign T-dependent antigens
require crosstalk between B cells and CD4+ T cells. After the binding
of B cells to their cognate antigen, B cells localise to the B:T border,
where they receive T-cell help. This interaction promotes extensive
cell division and the migration of B cells to the B-cell follicles. Later
on, the highly proliferative B-cell blasts differentiate into germinal
centre cells or antibody-secreting cells (plasmablasts). These
rapidly emerging plasmablasts are found in the extrafollicular
tissue where they continue to expand until they cease proliferation
and enter apoptosis (Maclennan et al, 2003; Tellier & Nutt, 2019). The
ability of B cells to quickly differentiate into short-lived antibody-
secreting cells to produce neutralising antibodies of different
isotypes can be critical to contain the spread of infections (Luther
et al, 1997). Among the genes that regulate the extrafollicular re-
sponse in a B-cell–intrinsic manner is microRNA-155 (Mir-155)
(Vigorito et al, 2007, 2013). We previously showed that mice lack-
ing miR-155 in B cells produce a lower number of IgM- and IgG-
secreting plasmablasts relative to their wild-type counterparts
(Vigorito et al, 2007). Furthermore, we identiﬁed PU.1 as a key miR-
155 target for this process (Lu et al, 2014). However, whether the loss
of cellularity of miR-155–deﬁcient plasmablasts is due to a dif-
ferentiation block, impaired proliferation or survival remains to be
understood. Here, we address this issue by tracking miR-155−/−–
activated B cells in vivo at critical stages of the extrafollicular
response. The earliest impairment of antigen stimulated miR-
155–deﬁcient B cells was observed at day 2.5, at the time that B cells
receive T-cell help, which precedes plasmablast differentiation.
From this time point onwards, miR-155–deﬁcient B-blasts and later
on plasmablasts displayed defective proliferation and increased
apoptosis. Gene expression analysis of miR-155–deﬁcient plas-
mablasts revealed dysregulation of genes involved in proliferation,
including DNA replication, cell cycle progression, and chromatin
organisation. Overall, our data demonstrate a complex mechanism
of plasmablast regulation by a single microRNA, which provides
new insight into antibody production during the early response to
infection.
Results and Discussion
We previously showed that miR-155 is critical to sustain an efﬁcient
extrafollicular response in a B-cell–intrinsic manner and that this
can be attributed in part to miR-155 regulation of PU.1 (Lu et al,
2014). To further understand the cellular basis by which miR-155
regulates the plasmablast response, we used the SWHEL adoptive
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transfer system (Phan et al, 2005). SWHEL transgenic B cells bear a
rearranged hen egg lysosome (HEL)–speciﬁc VDJH element targeted
into the IgH chain locus combined with an HEL-speciﬁc k L-chain
transgene (Phan et al, 2005). CD45.2+ Mir-155+/+ or Mir155−/− SWHEL
B cells were adoptively transferred into wild-type CD45.1+ congenic
recipients and immunised with HEL coupled to sheep red blood
cells (HEL-SRBCs—Fig 1A) to promote a T-dependent response.
We started by measuring the effect of miR-155 on the kinetics of
the B-cell response. In the SWHEL system, B-cell blasts can be
detected in the periarteriolar lymphoid sheath as early as 1 d
after HEL-SRBC immunisation and commence proliferation from 1.5 d
(Chan et al, 2009), and plasmablasts can be detected at day 3.5,
they peak by day 4.5 and rapidly decline afterwards (Paus et al,
2006; Phan et al, 2005). Adoptively transferred miR-155–sufﬁcient or
miR-155–deﬁcient splenic B cells were stained for HEL B-cell receptor
(BCR) in combination with CD45.1, CD45.2, CD138, FAS, and B220 and
quantiﬁed using ﬂow cytometry. In accordance with previous phe-
notypic characterisation of B-cell populations in the SWHEL system
(Chan et al, 2009), B-cell blasts were detected as HEL binding, B220+
cells during the early phase of the response and later plasmablasts
were identiﬁed as HEL BCR+, B220lo. Plasmablast B cells have pre-
viously been shown to be Blimp-1+ (Chan et al, 2009) and virtually all
of these cells also expressed CD138 (Fig 1B). In addition, germinal
centre B cells were detected as HEL BCR+, B220hi. These cells were
Figure 1. miR-155 is required to sustain the plasmablast B-cell response.
(A) A representative histogram showing HEL expression level on conjugated HEL-SRBCs (red) compared with unstained control (grey). (B) Representative ﬂow cytometric
plot showing gating strategy for SWHELMir155+/+ B cells at days 4.5 post immunisation, for identiﬁcation of CD45.2+ donor derived HEL BCR+, B220lo plasmablast B cells or HEL
BCR+, B220hi germinal centre B cells. (C) The number of SWHELMir155+/+ (black) orMir155−/− (grey) HEL-speciﬁc B-cell blasts, plasmablast B cells and germinal centre B cells
was calculated per 106 lymphocytes after immunisation in mice (N = 16–19 independent Mir155+/+ samples and 10–24 independent Mir155−/− samples). Data are
representative of at least two independent experiments. For B-cell blast data, aWelch’s t test was used. For plasmablast and germinal centre data, P-values are from t tests
using the error mean square from the ANOVA. (D) HEL-speciﬁc antibodies of the indicated immunoglobulins were measured in the serum of mice injected with SWHEL
Mir155+/+ (black) or Mir155−/− (grey) B cells, at day 4.5 post immunisation with HEL-SRBCs. Red dotted line represents statistical analysis of indicated Mir155+/+ or Mir155−/−
values using two-way ANOVA with Sidak’s multiple comparison test where **P < 0.01, ***P < 0.001, ****P < 0.0001.
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also shown to be virtually all FAS+ (Fig 1B). In the absence ofmiR-155,
we found a signiﬁcant reduction in the number of B-cell blasts at
day 3.5 post immunisation (Fig 1C). In addition, there was an almost
70% decrease in the mean number ofMir155−/− plasmablasts at day
3.5 compared with Mir155+/+ cells, which became more severe at
days 4.5 and 6.5 when the mean number of Mir155−/− plasmablasts
decreased by more than 90% compared with Mir155+/+ plasma-
blasts (Fig 1C). Although the peak of the response in Mir155−/−
plasmablast B cells was also at day 4.5, it dramatically collapsed by
day 6.5, a ﬁnding similar to that observed in the absence of IL-21
receptor in activated SWHEL B cells (Lee et al, 2011). We also ob-
served a reduction in the number of germinal centre B cells in the
absence of miR-155 at days 3.5, 4.5, and 6.5 (Fig 1C). In support of our
observations, the production of HEL-speciﬁc antibodies of all
subclasses examined, IgM, IgG1, IgG2b, IgG2c, and IgG3 isotypes, at
day 4.5 was also signiﬁcantly decreased in the absence of miR-155
(Fig 1D). At this time point, most of the antigen-speciﬁc antibody in
serum is expected to be secreted by plasmablasts (Chan et al, 2009).
These results indicate that the differentiation programme from
activated B cells to extrafollicular plasmablasts is not abolished in
the absence of miR-155; however, the number of differentiated cells
is severely impaired resulting in a contracted and suboptimal
response.
After establishing that miR-155 was critical for the plasmablast
B-cell response, we next sought to determine the underlying cel-
lular mechanisms. We started by monitoring the proliferation of
antigen speciﬁc B cells. Division of antigen-speciﬁc B-cell blasts
was assessed by CFSE dilution of HEL-binding, B220+ cells every 24 h
from 0.5 to 3.5 d post immunisation, a time when CFSE completely
dilutes out. B cells lacking miR-155 showed a reduced proportion of
highly dividing cells compared with wild-type at 2.5 d post
immunisation, an effect which continued at day 3.5 (Fig 2A and B).
The reduced number of proliferating cells could be due to a defect
in cell cycle or apoptosis or both. To disentangle this, we analysed
the cell cycle proﬁle of SWHEL plasmablast B cells either sufﬁcient or
deﬁcient inmiR-155 at days 3.5 and 4.5 post immunisation. We chose
those time points to analyse because of the onset of the plas-
mablast response at day 3.5 and because the number of Mir155−/−
plasmablasts is highest at day 4.5, allowing robust detection. When
DNA was quantiﬁed with DAPI, at day 3.5, there was a lower fre-
quency of cells in the S-G2-M stage of the cell cycle in SWHEL
Mir-155−/− plasmablast B cells compared with SWHEL Mir-155+/+
plasmablasts and an increase in the frequency of cells in the G1
stage, which became statistically signiﬁcant at day 4.5 (Fig 2C and D).
Supporting this observation, we also measured the amount of
plasmablast cells undergoing DNA replication at days 3.5, 4, and 4.5
by administering a pulse of the thymidine analogue 5-ethynyl-29-
deoxyuridine (EdU). SWHEL Mir155−/− plasmablast B cells at all time
points exhibited decreased incorporation of EdU compared with
SWHEL Mir155+/+ plasmablasts, suggesting a defect in DNA replica-
tion (Fig 2E and F). This indicated a requirement for miR-155 in the
progression between the G1 and S phases of the cell cycle.
Next, we asked whether miR-155–deﬁcient B cells were un-
dergoing increased apoptosis compared with their wild-type
counterparts. Flow cytometry was used to analyse the frequency
of active caspases in miR-155–sufﬁcient or miR-155–deﬁcient SWHEL
plasmablast B cells at 3.5 and 4.5 d post HEL-SRBC immunisation.
We found that Mir155−/− plasmablasts expressed a signiﬁcantly
increased proportion of active caspases compared with Mir155+/+
plasmablasts at both 3.5 and 4.5 d after activation (Fig 3A and B). The
magnitude of the increase in caspase expression was greater as
plasmablast differentiation progressed from day 3.5 to day 4.5. In an
attempt to rescue the number ofMir155−/− plasmablasts by blocking
apoptosis, we crossed the SWHEL Mir155+/+ or SWHEL Mir155−/− mice
with human Bcl2 transgenic mice, which express human BCL2 in all
haematopoietic cells (Ogilvy et al, 1999). We found that the Bcl2
transgene was expressed equivalently in Mir155+/+ or Mir155−/−
plasmablasts (Fig 3C). After adoptive transfer and HEL-SRBC
immunisation, the presence of the Bcl2 transgene substantially
increased the relative frequency (Fig 3D) and number (Fig 3E) of
miR-155–deﬁcient plasmablasts. The mean number of SWHEL Mir-
155+/+ plasmablast B cells increased 1.3-fold in the presence of the
Bcl2 transgene, whereas the number of SWHEL Mir-155−/− plasma-
blast B cells increased 2.5-fold in the presence of the Bcl2 trans-
gene, further supporting a role for miR-155 in maintenance of
plasmablast survival. However, despite a partial rescue in the
number of miR-155–deﬁcient plasmablasts, the number was not
fully restored to wild-type levels, even when the frequency of active
caspases was reduced (Fig 3F). These data suggest that the phe-
notype observed in miR-155–deﬁcient plasmablast B cells is due in
part to apoptosis of these cells, but that other mechanisms also
play a role.
We next sought to determine the molecular pathways disrupted
in SWHEL Mir155−/− plasmablast B cells by comparing the tran-
scriptome to wild-type counterparts. CD45.2+ HEL BCR+ B220lo
plasmablast B cells either sufﬁcient or deﬁcient for miR-155 were
sorted to more than 98% purity (Fig 4A) and their transcriptome
analysed by microarray at 4.5 d post immunisation. We deﬁned
differentially expressed genes as those genes with a fold change of
at least 1.3 between Mir155−/− and Mir155+/+ plasmablasts and a
corrected P-value of less than 0.05. We observed 410 genes with
increased mRNA abundance and 652 genes with decreased mRNA
abundance in Mir155−/− plasmablasts relative to their wild-type
counterparts. We then use the gene ontology (GO) enrichment
analysis tool GOrilla (Eden et al, 2009) to look for pathway en-
richment in the differentially expressed genes. Decreased and
increased genes were sorted into functional processes and ranked
according to their P-value (Tables S1 and S2). One of the most
signiﬁcantly decreased processes was translation. In addition, DNA
replication and cell cycle were amongst some of the other most
signiﬁcant gene sets which were decreased in Mir155−/− plasma-
blasts (Fig 4B), data which also complimented our ﬂow cytometric
results. We observed overall the highest number of down-regulated
genes in total associated with cellular and metabolic processes;
however, the highest percentage of differentially regulated genes
was shown to be largely associated with DNA replication and cell
cycle mechanisms. For example, DNA unwinding, DNA strand
elongation, and nucleosome organisation showed that 62.5%,
71.43%, and 77.27% of genes were differentially expressed, respec-
tively (Table S1). We validated the diminished expression of selected
genes involved in DNA replication and cell cycle, including c-myc,
E2F1, E2F2, and c-myb, by RT-qPCR and found that in Mir155−/−
plasmablasts, the expression of each was signiﬁcantly lower than in
wild-type cells (Fig 4C). Geneswith increasedmRNA abundancewere
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also analysed using GOrilla. Some of the up-regulated processes
involved regulation of cellular metabolic processes, mRNA splicing,
as well as histone and chromatin modiﬁcation (Fig 4D and Table S2).
The results in this report demonstrate a critical in vivo role for
miR-155 in proliferation and survival of plasmablast B cells in re-
sponse to the T-cell–dependent antigen HEL. We have used the
SWHEL system to demonstrate that the impact of miR-155 deﬁciency
becomes evident in B-cell blasts as early as 2.5 d after antigen
stimulation, preceding differentiation into plasmablasts and also
germinal centres. As B-cell blasts expand into extrafollicular
plasmablasts, we show an essential role for miR-155 in sustaining
the number of plasmablast B cells and in the production of class-
switched antibodies. The data suggest that failure of miR-155
deﬁciency in sustaining the extrafollicular plasmablast response is
due to impaired cell cycle progression and increased apoptosis.
Indeed, it has been shown previously that B-cell differentiation and
isotype switching in vitro requires cell division (Hodgkin et al, 1996)
and miR-155–deﬁcient splenic B cells cultured with LPS and IL-4
exhibited reduced frequency of CFSE+ CD138+ B cells compared with
wild-type mice (Lu et al, 2014). At the peak of the plasmablast
response, mechanistically miR-155 deﬁciency resulted in decreased
mRNA abundance of genes involved in DNA replication, cell cycle
progression, and chromatin organisation in an indirect manner.
Some of these down-regulated genes included cell cycle regulators
such as E2F1, E2F2, and Myc, which have been observed to affect
B-cell differentiation in other systems (Lam et al, 1999; Shaffer et al,
Figure 2. miR-155 is essential for the optimal proliferation of plasmablast B cells.
(A) SWHEL Mir155+/+ (black line) orMir155−/− (grey line) HEL-binding, B220+ B cell blasts were assessed for different CFSE dilutions. (B) The percentage of CFSE+ cells in each
division at days 2.5 and 3.5 post immunisation. The generation number is indicated above each data set. A two-way ANOVA with Sidak’s multiple comparison test was used.
Values shown are mean ± SD. (C) Cell cycle analysis using DAPI staining was carried out on SWHEL Mir155+/+ or Mir155−/− plasmablast B cells at 3.5 and 4.5 d post
immunisation. The frequency of cells in the S-G2-M phases inMir155+/+ (black) orMir155−/− (grey) plasmablasts is shown. A nonparametric Mann–Whitney test was used per
time point. (D) Representative ﬂow cytometry plot of DAPI staining at 4.5 d post immunisation in miR-155–sufﬁcient or miR-155–deﬁcient plasmablast B cells. Cells
previously gated on lymphocytes and single cells. (E) EdU incorporation in SWHEL Mir155+/+ (black) or Mir155−/− (grey) plasmablast B cells at the time points indicated post
immunisation. Two-way ANOVA was used. There was no signiﬁcant interaction between genotype and day, but both genotype and day had signiﬁcant effects P < 0.001. (F)
Representative ﬂow cytometry histograms of EdU incorporation in wild-type (WT, black line) or miR-155–deﬁcient plasmablast B cells (black line) compared with
plasmablast B cells from control mice not injected with EdU (grey) at 4 d post immunisation. Data are representative of at least two independent experiments.
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2002). Previously, most of the roles of miR-155 in B-cell differen-
tiation have been attributed to regulation of the germinal centre
response, whereas the requirement for miR-155 in the extra-
follicular plasmablast response has not been well characterised.
Our data are signiﬁcant in elucidating miR-155 as a new player in
the early expansion of antigen-speciﬁc B-cell blasts into extra-
follicular plasmablasts, which is necessary for short-term immune
protection to infection (Nutt et al, 2015). The onset of the pro-
liferation defect in Mir155−/− B-cell blasts occur at the stage of B:T
cell interaction, and we also previously showed that dysregula-
tion of PU.1 by miR-155 in cultured B cells affects the expression of
genes involved in adhesion and B:T cell interaction (Lu et al,
2014). However, SWHEL Mir155−/− mice from day 3.5 post HEL-SRBC
immunisation are still able to form germinal centres or locate in the
red pulp (Nakagawa et al, 2016), suggesting that loss of cellularity in
the absence of miR-155 is not explained by impaired migration and
that, to some extent, miR-155–deﬁcient B-cell blasts are responsive
to T-cell help. The resemblance of our phenotype to that observed
in IL-21 or IL-21R receptor–deﬁcient mice (Lee et al, 2011), however,
may indicate a potentially impaired response to T-cell help. In the
absence of IL-21R, both the extrafollicular plasmablast and the
germinal centre responses are impaired to ~10% of wild-type
numbers (Lee et al, 2011), similar to what we have observed in
miR-155–deﬁcient mice. Furthermore, in one report, IL-21 signalling
and miR-155 was reported to be linked in CD4+ T cells from systemic
lupus erythematosus patients (Rasmussen et al, 2015). It would,
Figure 3. miR-155 regulates survival of plasmablast B cells.
(A) SWHEL HEL BCR+ B220lo Mir155+/+ (black) or Mir155−/− (grey) plasmablast B cells were analysed for activated caspases at the time points shown. A nonparametric
Mann–Whitney test was used per time point. (B) Representative ﬂow cytometry histograms of cleaved caspase detection in wild-type or miR-155−/− SWHEL plasmablast
B cells at day 4.5 post immunisation. (C) Expression of the human Bcl2 transgene (huBCL2) in SWHEL Mir155+/+ × Bcl2 (black line) or SWHEL Mir155−/− × Bcl2 (solid grey
line) plasmablast B cells, compared with negative control (single grey line). (D) Representative FACS plot showing the gating strategy for analysis of adoptively
transferred SWHEL Mir155+/+ or Mir155−/− B cells expressing a human Bcl2 transgene at day 4.5 post immunisation. Plots were previously gated on lymphocytes and single
cells and analysed for CD45.2 donor cells and HEL+ B220lo plasmablast B cells. HEL+ B220hi germinal centre B cells could also be visualised in all mouse strains. (E)
The number of splenic SWHEL Mir155+/+ or Mir155−/− plasmablast B cells in mice with or without the expression of a human Bcl2 transgene per 106 lymphocytes. A
nonparametric Kruskal–Wallis with Dunn’s multiple comparisons test was used where **P < 0.01. (F) The frequency of active caspases in miR-155–sufﬁcient and miR-
155–deﬁcient plasmablast B cells at day 4.5 post immunisation. At least two independent experiments were carried out. Statistics calculated using nonparametric
Kruksal–Wallis with Dunn’s multiple comparisons test where *P < 0.05, **P < 0.01, ****P < 0.0001. Data are representative of at least two independent experiments.
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therefore, be interesting to investigate further whether the defects
observed with miR-155 deﬁciency are linked to defective IL-21
signalling.
Materials and Methods
Mice
CD45.1+ congenic mice were bred and maintained in the Babraham
Research Campus small animal facility. SWHEL mice and miR-155–
deﬁcient mice and have been described previously (Phan et al,
2003; Rodriguez et al, 2007). SWHEL mice were a gift from R. Brink
(Garvan Institute of Medical Research/University of New South
Wales). All mice were on the C57BL/6 background and bred and
maintained in the Biological Support Unit of Babraham Institute
under speciﬁc opportunistic pathogen-free conditions.
Adoptive transfer
SWHEL Mir155+/+ or SWHEL Mir155−/− donor B cells were adoptively
transferred into nonirradiated CD45.1+ congenic recipient mice
followed by injection of 2 × 108 HEL-SRBCs (Fig 1A). HEL (Sigma-
Aldrich) was conjugated to SRBCs, and expression was sub-
sequently measured with anti-HEL HyHEL9 antibody by ﬂow
cytometry. For proliferation experiments, donor B cells were la-
belled with 5 µM CFSE before adoptive transfer. For EdU in-
corporation studies, mice were injected with EdU i.p. 4 h before
being euthanised. Spleen cells from mice were analysed by ﬂow
cytometry on the indicated days. For FACS analyses, CD45.2+ donor
Figure 4. miR-155 regulates the expression of genes associated with DNA replication.
(A) Representative gating strategy showing CD45.2+ plasmablast B cells before and after suboptimal depletion of CD45.1+ cells. After enrichment, SWHEL Mir155+/+ or Mir155−/−
plasmablast B cells were sorted on a FACS Aria to more than 98% purity and analysed by microarray analysis. N = 4–5 Mir155+/+ and 8–10 Mir155−/− mice at day 4.5 post
immunisation. (B) Differentially expressed (DE) genes with known functions were discovered by GOrilla analysis using the genes that were down-regulated in SWHEL
Mir155−/− plasmablasts compared with SWHELMir155+/+ plasmablasts. (C) ThemRNA abundance of down-regulated genes with reported roles in DNA replication and function in
Mir155−/− plasmablasts relative to Mir155+/+ plasmablasts (dotted line) was conﬁrmed by RT-qPCR. Expression values are normalized to HPRT, determined from three to
four biological replicates from three to four independent sorting experiments using 4–5Mir155+/+ or 8–10Mir155−/−mice per group. (D)GOrilla analysis of the DE genes that were
up-regulated in SWHEL Mir155−/− plasmablast B cells compared with SWHEL Mir155+/+ plasmablast B cells.
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splenocytes were enriched by CD45.1-negative selection using an
autoMACS pro separator (Miltenyi Biotec).
Flow cytometry
Multicolor ﬂow cytometry for analysis or for sorting was performed
on an LSR Fortessa-5 or FACS Aria (BD Biosciences), respectively.
Single-cell suspensions of splenocytes were blocked with anti-
CD16/32 mAb (clone 2.4G2), followed by staining with the follow-
ing antibodies: anti-B220 (clone RA3-6B2) and anti-CD45.2 (clone
104) from BD Biosciences. HEL-binding B cells were stained as
described previously (Chan et al, 2009). For cell cycle analyses,
spleen cells were ﬁrst stained for extracellular antigens and then
were analysed with 10 μg/ml DAPI staining using a Cytoﬁx/
Cytoperm kit (BD Biosciences) or PFA and Tween-20. Cell cycle
was calculated by FlowJo Dean/Jett/Fox algorithm or by setting
gates manually. The Click-iT EdU Alexa Fluor 488 Imaging kit and
CaspGLOW Fluorescein Active Caspase Staining kit (both from
Thermo Fisher Scientiﬁc) were used according to the manufac-
turer’s instructions. Data were analysed with FlowJo software (Tree
Star).
Microarray
After sorting of plasmablast B cells directly into Trizol, RNA was
extracted and resuspended in RNAse-free water. RNA that passed
quality control using a bioanalyzer and NanoDrop was subject to
rounds of ampliﬁcation using the Ambion Expression kit. cDNA
from ﬁve independent biological samples of SWHEL Mir155+/+– or
SWHEL Mir155−/−–sorted plasmablast B cells were hybridized to
GeneChip Mouse Gene ST1.0 arrays (Affymetrix) according to the
manufacturer’s instructions. Bioconductor package affy and the
robust multiarray average function were used for background
correction, and normalization was performed using the software
package R by the Babraham Bioinformatics facility. Normalized
data were ﬁltered with a threshold of the modal expression value
in which three of the ﬁve samples had to exceed the log2 modal
expression threshold. Differentially expressed genes between
miR-155–sufﬁcient or miR-155–deﬁcient plasmablast B cells were
assessed using a P-value less than 0.05 and a fold change of
greater than 1.3-fold.
Gene ontology analysis
Differentially expressed genes in miR-155–deﬁcient plasmablast
samples were computed using the GOrilla tool (Eden et al, 2009) to
determine enriched gene ontology terms. A background list of
genes was included in the analysis. If several related terms were
signiﬁcantly enriched, the terms with a higher percentage of
differentially expressed genes were chosen, and are presented in
Fig 4.
DNA isolation, RNA extraction, and RT-qPCR assays
Total RNAwas extracted from sorted plasmablast populations using
TRIzol (LifeTech). RNA from sorted plasmablast B cells was con-
verted to cDNA according to the superscript reverse transcriptase III
protocol (Invitrogen) and then analysed by RT-qPCR. Cell cycle
genes E2F1, E2F2, Myc, and Myb were analysed using custom or
commercially available primers (see Table S3). E2F1 and E2F2 mRNA
transcript expression was analysed using primers according to
Pilon et al (2008). Myc, E2F1, and E2F2 RT-qPCR assays were analysed
using Platinum SYBR Green qPCR SuperMix (Life Technologies).
Relative abundance was calculated using a standard curve or δ CT
method and normalized to the expression of mRNA-encoding HPRT.
Myb RT-qPCR assays were performed with Taqman assays. Ex-
pression of Myb mRNA was calculated using a standard curve and
normalized to the expression of β2M.
Statistics
Statistical analyses were performed in GraphPad Prism software or
R Studio; tests are indicated in the ﬁgure legends. All data were
tested for normality of residuals. If data were normally distributed,
parametric tests were used. For non-normally distributed data,
several transformations were attempted, and if this was satisfac-
tory, parametric tests were used. Where transformation of data
yielded non-normally distributed residuals, nonparametric tests
were used. For B-cell blasts number, data were square-root
transformed. For testing the effects of genotypes on plasmablast
and germinal centre cell number, the data were log-transformed
and tested by two-way ANOVA. There was a signiﬁcant interaction
between genotype and time. For CFSE data, the values were arcsine-
transformed. For EdU incorporation data, the values were arcsine-
transformed and tested by two-way ANOVA.
Study approval
All mouse experiments were approved by the Animal Welfare and
Ethical Review Body of the Babraham Institute. Animal husbandry
and experimentation complied with the existing European Union,
United Kingdom Home Ofﬁce legislation and local standards.
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Supplementary Information is available at https://doi.org/10.26508/lsa.
201800244.
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